The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC
Clinical trial NCT06139419 · COMPLETED
Trial details
- NCT number
- NCT06139419
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2026-06-30
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.